Core Laboratories
CLB
181 hedge funds and large institutions have $1.14B invested in Core Laboratories in 2020 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 49 increasing their positions, 78 reducing their positions, and 28 closing their positions.
103% more call options, than puts
Call options by funds: $4.21M | Put options by funds: $2.07M
81% more capital invested
Capital invested by funds: $630M → $1.14B (+$513M)
2.76% more ownership
Funds ownership: 94.08% → 96.84% (+2.8%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3% less funds holding
Funds holding: 187 → 181 (-6)
14% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 28
37% less repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 78
Top Buyers
| 1 |
AI
Ariel Investments
Chicago,
Illinois
|
+$27.4M |
| 2 |
FAM
Fred Alger Management
New York
|
+$21.6M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$9.69M |
| 4 |
RRAM
River Road Asset Management
Louisville,
Kentucky
|
+$4.59M |
| 5 |
VanEck Associates
New York
|
+$2.92M |
Top Sellers
| 1 |
Truist Financial
Charlotte,
North Carolina
|
-$9.44M |
| 2 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$6.17M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$4.38M |
| 4 |
MPI
Mairs & Power Inc
St Paul,
Minnesota
|
-$3.11M |
| 5 |
HF
HRT Financial
New York
|
-$2.58M |
CLB Hedge Fund Activity: Q4 2020 in Review
181 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Core Laboratories (CLB) for Q4 2020, worth a combined $1.14B — up 81% from $630M a quarter earlier.
Sellers outnumbered buyers: 28 funds closed out of CLB and 24 opened new positions — a net loss of 4 holders — while 78 trimmed existing stakes and 49 added.
The largest buyer was Ariel Investments, adding an estimated $27.4M. The largest seller was Truist Financial, cutting an estimated $9.44M.
- 181 institutional investors held Core Laboratories (CLB) as of Q4 2020, down from 187 in Q3 2020.
- Funds reported $1.14B of Core Laboratories stock for Q4 2020, up 81% quarter-over-quarter.
- 24 funds opened new Core Laboratories positions in Q4 2020 and 28 closed out, a net change of -4 holders.
- The largest Core Laboratories buyer in Q4 2020 was Ariel Investments, an estimated $27.4M added.
- The largest Core Laboratories seller in Q4 2020 was Truist Financial, an estimated $9.44M sold.
Based on aggregated 13F filings for Q4 2020.